High-Dose IVIG, Rituximab Effective in Patients With Pemphigoid-Associated Conjunctivitis
In patients with ocular cicatricial pemphigoid (OCP) and mucous membrane pemphigoid with ocular involvement (ocMMP), treatment with high-dose intravenous immunoglobulin (IVIG) and rituximab (Rituxan; Genentech and Biogen Idec) was found to be effective at …